Although the Danish drugmaker anticipates adverse development for the very first time this millennium, chief executive officer Mike Doustdar claims this must not be viewed as a dilemma. Capitalist differs.
发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/novo-nordisk-ceo-refutes-crisis-despite-negative-growth-forecast/